RxDoctor Payments DataLook up a doctor →

Dan Streja

Endocrinology, Diabetes & Metabolism · West Hills, CANPI 1467464404

Payments from drug & device makers

$2,999,791in general payments, 2019–2025

Across 2,023 payments — averaging $1482.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$1.5M
  • Novo Nordisk AS$487K
  • Pfizer$388K
  • Eli Lilly$370K
  • Regeneron$145K
  • Sanofi-aventis U.S. LLC$28K
  • plus $53K from 15 others
$8,918in research payments, 2019–2025

Across 2 payments — averaging $4458.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi US Services Inc.143$1,529,014
Novo Nordisk AS1,187$487,142
Pfizer65$387,876
Eli Lilly5$370,254
Regeneron371$144,544
Sanofi-aventis U.S. LLC22$27,536
Novartis7$24,145
AbbVie19$18,132
Bayer11$5,995
AstraZeneca5$1,581
Novo Nordisk100$1,485
Boehringer Ingelheim33$715
Lilly USA, LLC12$324
Dexcom, Inc.12$295
Mannkind Corporation13$254
Abbott2$145
Medtronic7$134
Amgen4$105
Merck3$47
Insulet Corporation1$42
Radius Health, Inc.1$24

How this compares

$2,999,791 in reported general payments places this provider in the 95th percentile of 952 endocrinology, diabetes & metabolism providers in California.

See all endocrinology, diabetes & metabolism providers in California

Other endocrinology, diabetes & metabolism in West Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →